These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11941385)

  • 21. Cardiorenal Safety of OTC Analgesics.
    White WB; Kloner RA; Angiolillo DJ; Davidson MH
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):103-118. PubMed ID: 29421936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin and acetaminophen: should they be available over the counter?
    Brune K; Hinz B; Otterness I
    Curr Rheumatol Rep; 2009 Feb; 11(1):36-40. PubMed ID: 19171110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of analgesics in the management of osteoarthritis pain.
    Brandt KD
    Am J Ther; 2000 Mar; 7(2):75-90. PubMed ID: 11319576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current perspective on the cardiovascular effects of coxibs.
    Konstam MA; Weir MR
    Cleve Clin J Med; 2002; 69 Suppl 1():SI47-52. PubMed ID: 12086293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.
    Vardeny O; Solomon SD
    Cardiol Clin; 2008 Nov; 26(4):589-601. PubMed ID: 18929233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents.
    Matzke GR
    Am J Kidney Dis; 1996 Jul; 28(1 Suppl 1):S63-70. PubMed ID: 8669432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase Inhibition: Pain, Inflammation, and the Cardiovascular System.
    Grosser T; Theken KN; FitzGerald GA
    Clin Pharmacol Ther; 2017 Oct; 102(4):611-622. PubMed ID: 28710775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
    Moore RA; Derry S; McQuay HJ
    BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older.
    Alchin J; Dhar A; Siddiqui K; Christo PJ
    Curr Med Res Opin; 2022 May; 38(5):811-825. PubMed ID: 35253560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal complications of prescription and over-the-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, Rheumatism, and Aging Medical Information System.
    Singh G
    Am J Ther; 2000 Mar; 7(2):115-21. PubMed ID: 11319579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current and emerging treatments for mild/moderate acute ambulatory pain.
    Weaver AL
    Am J Ther; 2008; 15 Suppl 10():S12-6. PubMed ID: 19127123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS
    JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain.
    Labianca R; Sarzi-Puttini P; Zuccaro SM; Cherubino P; Vellucci R; Fornasari D
    Clin Drug Investig; 2012 Feb; 32 Suppl 1():53-63. PubMed ID: 22356224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical update on benefit versus risks of oral paracetamol alone or with codeine: still a good option?
    Kress HG; Untersteiner G
    Curr Med Res Opin; 2017 Feb; 33(2):289-304. PubMed ID: 27842443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.
    Scheiman JM; Fendrick AM
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying the impact of NSAID-associated adverse events.
    Fine M
    Am J Manag Care; 2013 Nov; 19(14 Suppl):s267-72. PubMed ID: 24494609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of over-the-counter analgesics.
    Whelton A
    J Clin Pharmacol; 1995 May; 35(5):454-63. PubMed ID: 7657844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians.
    Scheiman JM
    J Clin Gastroenterol; 2016 Jan; 50(1):5-10. PubMed ID: 26524151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.